You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 127 No. 5, May 1992 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLE
 This Article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Technical and biological factors in disease-free survival after hepatic resection for colorectal cancer metastases

B. Cady, M. D. Stone, W. V. McDermott Jr, R. L. Jenkins, A. Bothe Jr, P. T. Lavin, E. J. Lovett and G. D. Steele Jr
Division of Surgical Oncology, New England Deaconess Hospital, Boston, Mass. 02215.

Careful patient selection for hepatic resection of colorectal cancer metastases is essential to improve current poor results. Carcinoembryonic antigen level and number of metastases were significant preoperative prognostic indicators of 5-year disease-free survival in patients selected clinically for hepatic surgery. Surgical margin, weight of hepatic tissue resected, carcinoembryonic antigen level, and flow cytometry were significant postoperative prognostic indicators. Patients with a carcinoembryonic antigen level less than 200 ng/mL, 1-cm surgical margins, and less than 1,000 g of liver tissue removed had a greater than 50% estimated 5-year disease-free survival rate. If the metastases were diploid on flow cytometry, an additional survival advantage may have been gained. Inadequate surgical margins led to high rates of liver-only recurrence. Nonhepatic recurrence was unrelated to surgical margins. Intraoperative liver examination by ultrasound during primary colon cancer resection and adjuvant chemotherapy may offer earlier selection of biologically appropriate patients and improved outcome; both recommendations require clinical trials.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Expanding Criteria for Resectability of Colorectal Liver Metastases
Pawlik et al.
The Oncologist 2008;13:51-64.
ABSTRACT | FULL TEXT  

Effect of subcentimeter nonpositive resection margin on hepatic recurrence in patients undergoing hepatectomy for colorectal liver metastases. Evidences from 663 liver resections
Figueras et al.
Ann Oncol 2007;18:1190-1195.
ABSTRACT | FULL TEXT  

Timing of Resection of Liver Metastases Synchronous to Colorectal Tumor: Proposal of Prognosis-Based Decisional Model
Capussotti et al.
Ann. Surg. Oncol. 2007;14:1143-1150.
ABSTRACT | FULL TEXT  

Survival After Hepatic Resection for Colorectal Metastases: A 10-Year Experience
Wei et al.
Ann. Surg. Oncol. 2006;13:668-676.
ABSTRACT | FULL TEXT  

The Significance and Clinical Factors Associated With a Subcentimeter Resection of Colorectal Liver Metastases
Wray et al.
Ann. Surg. Oncol. 2005;12:374-380.
ABSTRACT | FULL TEXT  

Current techniques and results of liver resection for colorectal liver metastases
Hamady et al.
Br Med Bull 2004;70:87-104.
ABSTRACT | FULL TEXT  

Analysis of Surgical Salvage After Failure of Primary Therapy in Rectal Cancer: Results From Intergroup Study 0114
Tepper et al.
JCO 2003;21:3623-3628.
ABSTRACT | FULL TEXT  

Liver Resection for Multiple Colorectal Metastases: Influence of Parenchymal Involvement and Total Tumor Volume, vs Number or Location, on Long-term Survival
Ercolani et al.
Arch Surg 2002;137:1187-1192.
ABSTRACT | FULL TEXT  

Genetic and Histological Assessment of Surgical Margins in Resected Liver Metastases From Colorectal Carcinoma: Minimum Surgical Margins for Successful Resection
Kokudo et al.
Arch Surg 2002;137:833-840.
ABSTRACT | FULL TEXT  

Reduction in Recurrence Risk for Involved or Inadequate Margins With Edge Cryotherapy After Liver Resection for Colorectal Metastases
Gruenberger et al.
Arch Surg 2001;136:1154-1157.
ABSTRACT | FULL TEXT  

Echogenicity of Liver Metastases Is an Independent Prognostic Factor After Potentially Curative Treatment
Gruenberger et al.
Arch Surg 2000;135:1285-1290.
ABSTRACT | FULL TEXT  

Interval Hepatic Resection of Colorectal Metastases Improves Patient Selection
Lambert et al.
Arch Surg 2000;135:473-480.
ABSTRACT | FULL TEXT  

Resection of Synchronous Liver Metastases from Colorectal Cancer
Fujita et al.
Jpn J Clin Oncol 2000;30:7-11.
ABSTRACT | FULL TEXT  

Molecular Detection of Neoplastic Cells in Lymph Nodes of Metastatic Colorectal Cancer Patients Predicts Recurrence
Sanchez-Cespedes et al.
Clin. Cancer Res. 1999;5:2450-2454.
ABSTRACT | FULL TEXT  

CT-monitored Percutaneous Cryoablation in a Pig Liver Model: Pilot Study
Lee et al.
Radiology 1999;211:687-692.
ABSTRACT | FULL TEXT  

Down-Regulation of p27 Is Associated with Development of Colorectal Adenocarcinoma Metastases
Thomas et al.
Am. J. Pathol. 1998;153:681-687.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1992 American Medical Association. All Rights Reserved.